Summary

Patients with multiple sclerosis (MS) commonly suffer from fatigue that negatively affects their functioning and quality of life. Both the cause and the consequences of MS fatigue are multidimensional and require multidisciplinary treatment for successful symptom management. This article presents the results of the Efficacy of L-carnitine Versus Placebo in the Treatment of Fatigue in Multiple Sclerosis study [FACTSEP; NCT01149525]